
Dbol
Live Price
Recent news and updates for DBOL will appear here soon.
"Balanced market signals for DBOL. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current consumer defensive growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Dhampur Bio Organics Limited, an integrated sugarcane processing company, engages in the manufacture and sale of refined, sulphitation, raw sugar, sugar, biomass-based renewable power, biofuels, potable liquor, chemicals, and allied products in India. The company operates through three segments: Sugar, Bio Fuels & Spirits, and Country Liquor. It also offers alcoholic beverages with 25% and 36% alcohol content; and ENA, a food-grade alcohol, as well as bagasse and organic fertilizer. In addition, the company manufactures and sells SDS, ethanol, sanitizer, etc., as well as engages in the co-generation and sale of power. The company also exports its products. Dhampur Bio Organics Limited was incorporated in 2020 and is based in New Delhi, India.
As of the latest market session, Dbol (DBOL) is trading at ₹102.09, representing a move of 0.68% from the previous close.
Dbol is listed and traded under the ticker symbol DBOL on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Dbol's stock price moved by 0.68%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Consumer Defensive industry.
Our proprietary AI Momentum engine calculates a 43% bullish probability for DBOL stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Dbol shares reached a high of ₹130.73 and hit a low of ₹69.
DBOL exhibits standard volatility for a Consumer Defensive stock, with an average daily trading volume of 53,471 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Dbol has a market capitalization of ₹673.68 Cr, designating its size class inside the Consumer Defensive sector.
Dbol has a current dividend yield of 147.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Dbol's trailing Price-to-Earnings (P/E) ratio is 26.81. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Dbol (DBOL) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Dbol's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore DBOL's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for DBOL are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Dbol operates inside the Consumer Defensive sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.